The EDQM reminds you that its office will be closed on Thursday 25 May and Friday 26 May 2017, due to a public holiday.
Supplements 9.1 to 9.5 of the European Pharmacopoeia are now available to order on the EDQM store. These supplements, which are expected to be ready for dispatch during June, contain all the regulatory information that will come into force in the course of 2018
The European Pharmacopoeia (Ph. Eur.) Commission has launched a public consultation on its proposal to include in its texts 4 plasticisers that can be added to PVC (poly(vinyl chloride)) for manufacturing blood containers and sets for blood transfusions.
The latest monthly activity report for the Certification of Substances Department (DCEP) is now available.
This 19th Edition of the Guide to the preparation, use and quality assurance of blood components was elaborated by a dedicated ad hoc working group of experts nominated by the European Committee (Partial Agreement) on Blood Transfusion.
Users of CEPs are invited to provide comments on draft monographs published in Pharmeuropa 29.2 before 30 June 2017.
On 24 January 2017, the Permanent Representation of the Republic of Moldova to the Council of Europe handed to Mr Thorbjørn Jagland, Secretary General of the Council of Europe, the instrument of accession to the Convention on the Elaboration of a European Pharmacopoeia [European Treaty Series n° 050], as amended by the Protocol of 16 November 1989.
On the occasion of World Haemophilia Day, the EDQM will provide a space for an event organised by the European Haemophilia Consortium (EHC) to address current challenges in the treatment of haemophilia. Representatives of patients’ associations, healthcare professionals and pharmaceutical industry will gather in Strasbourg to discuss the state of haemophilia care in Europe with the objective of...
The European Pharmacopoeia (Ph. Eur.) is consulting the public on three new texts, which for the first time in Europe, propose harmonised quality standards for Live Biotherapeutic Products (LBPs) used in human healthcare.
Pharmeuropa contains draft pharmacopoeial texts for which the European Pharmacopoeia Commission is seeking comment.
Pending completion of the review of the related substances test published in European Pharmacopoeia 9.0 by the group of experts, and to ensure a continuing supply of erythromycin ethylsuccinate active substance to the European markets, a revised monograph has been prepared and will be effective from 01 May 2017.
The European Pharmacopoeia Commission is seeking public feedback on its proposal to remove the requirements for a test for abnormal toxicity from 49 monographs of the European Pharmacopoeia (Ph. Eur.).
The European Pharmacopoeia (Ph. Eur.) Commission adopted 15 new monographs at its 157th Session, which took place in Strasbourg on 21-22 March.
The European network of Official Medicines Control Laboratories has highlighted how new analytical techniques will support national authorities, such as health government agencies, customs, police and courts, in the fight against falsified medicines. More than 95 participants from 27 countries, gathered in Nicosia on 28-29 March 2017.
A Poster session will be organised during the Conference and workshop on 'Sharing best practices for the implementation of Quality Management Systems in Blood Establishments (BEs)', 17-19 October 2017 in Strasbourg, France. Poster abstracts can be submitted until 30 April 2017.